Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Clearside Biomedical, Inc. (CLSDQ) vs Decoy Therapeutics Inc (DCOY)

Clearside Biomedical, Inc. and Decoy Therapeutics Inc are both Biotechnology companies. Clearside Biomedical, Inc. and Decoy Therapeutics Inc are of similar size ($2.2M and $2.0M). Clearside Biomedical, Inc. has negative trailing earnings, so its P/E is not meaningful; Decoy Therapeutics Inc trades at 0.0×. Clearside Biomedical, Inc. grew revenue faster over the last twelve months: −56.8% against −60.5%. Decoy Therapeutics Inc has the higher net margin (−698.8% vs −780.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Clearside Biomedical, Inc. leads on 9 and Decoy Therapeutics Inc on 6.

Valuation

Metric CLSDQ DCOY Biotechnology median
P/E n/m 0.02 7.88
P/S 0.39 0.79 11.47
P/B n/m 0.38 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.42 0.74
EV/Sales 10.91 (2.99) 10.73
Earnings yield (2,075.24%) 5,960.59% (28.84%)
Free cash flow yield (1,661.90%) (637.25%) (23.03%)

Profitability

Metric CLSDQ DCOY Biotechnology median
Gross margin 92.55% 10.57% 65.16%
Operating margin (689.76%) (706.88%) 0.00%
Net margin (780.93%) (698.79%) 0.00%
Free cash flow margin (653.23%) (432.43%) 0.00%
Return on equity 58.59% (827.77%) (57.72%)
Return on assets (127.43%) (278.04%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLSDQ DCOY Biotechnology median
Revenue growth (TTM) (56.78%) (60.49%) 5.64%
EPS growth (last fiscal year) 11.32% (85.66%) —
Revenue growth, 5-year CAGR (5.20%) 12.73% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLSDQ DCOY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.98 1.83 4.73
Net debt to EBITDA 0.69 0.85 0.96

Dividend

Metric CLSDQ DCOY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLSDQ DCOY Biotechnology median
Market cap 2.15m 1.99m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack